A new agreement between TeraGroup and UAE APEX will facilitate further investigation as well as the progression of a coronavirus device.
APEX National Investment, a corporation in the United Arab Emirates (UAE), has announced the signing of a strategic industry agreement with the Israeli organization TeraGroup to expand and study on the new coronavirus (COVID-19), the UAE news firm (WAM) reported.
According to the report, the agreement signed through APEX’s National Investments President Khalifa Yousef Khouri and TeraGroup’s CHIEF Executive, Oren Sadiv, at a press convention held at Al Qudra Holding headquarters in the emirate of Abu Dhabi.
The convention was attended by first capital group representative Ido Berniker, as well as several Israeli and Emirati dignitaries, business leaders and media representatives.
Commenting on the new agreement, Khalifa Yousef Khouri said: “We are very pleased with this cooperation with TeraGroup, which is the first company to inaugurate effective trade, economy and partnerships between the Emirati and Israeli trade sectors, at the service of humanity. studies on the new coronavirus (COVID-19) “.
Oren Sadiv (COVID-19) worldwide. “
“I would like to thank SE Khalifa Yousef Khouri and Mr. Oren Sadiv and we are pleased to point out this industrial agreement between APEX National Investment, which specializes in investments and clinical fields in Abu Dhabi, and TeraGroup, a world leader in the Terahertz field,” said Ido Berniker. “At First Capital Group, we are willing to incorporate combined science and invention corporations to identify advertising and investment partnerships with Emirati corporations, such as APEX National Investment.
The agreement between corporations focuses on achieving and obtaining better studies and studies of coronavirus, as well as the progression of a coronavirus test device that will help speed up the testing process, facilitate and deliver it with the highest precision and best for all, in accordance with the most productive foreign practices.